A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas
Clinical trial NCT02700022 · TERMINATED
Trial details
- NCT number
- NCT02700022
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2016-11-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.